The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model

María Del Mar García-Suárez1, Noelia Flórez, Aurora Astudillo

  • 1Area de Microbiología, Departamento de Biología Funcional, Instituto Universitario de Biotecnología de Asturias, Universidad de Oviedo, Oviedo, Asturias, Spain. margarciasuarez@yahoo.es

Respiratory Research
|January 30, 2007
PubMed
Abstract

Insights

Pneumolysin (PLY) from Streptococcus pneumoniae causes fatal pneumonia by promoting apoptosis and inflammation, not direct cell killing. Antibody treatment reduced lung damage, highlighting PLY

Area of Science:

  • Microbiology
  • Immunology
  • Pathology

Background:

  • Streptococcus pneumoniae causes fatal pneumonia in mice.
  • Pneumolysin (PLY) is a key virulence factor implicated in disease pathogenesis.

Purpose of the Study:

  • To investigate the role of pneumolysin (PLY) in a mouse model of pneumococcal pneumonia.
  • To determine if PLY's cytotoxic or inflammatory/apoptotic effects drive lung injury.

Main Methods:

  • ELISA for PLY quantification.
  • Immunohistochemistry for PLY distribution, caspase-9 activity, and TUNEL assay.
  • Quantification of inflammatory and apoptotic cells in lung tissue.

Main Results:

  • Sublytic concentrations of PLY were found in alveolar macrophages and leukocytes.
  • Apoptosis patterns mirrored PLY distribution.
  • Anti-PLY antibody treatment reduced lung damage and cellular inflammation/apoptosis.

Conclusions:

  • Pneumolysin (PLY) induces lung injury primarily through pro-apoptotic and pro-inflammatory mechanisms, not direct cytotoxicity.
  • PLY contributes to host cell apoptosis and lethal inflammation, aiding pathogen survival.